Markers of human papillomavirus infection and their correlation with cervical dysplasia in human immunodeficiency virus-positive women

Clinical Microbiology and Infection

Volumn 13, Issue 1, 2007, Pages 94-97

  Riva, E ^a   Serraino, D ^b,c   Pierangeli, A ^d   Bambacioni, F ^a   Zaniratti, S ^b   Minosse, C ^b   Selleri, M ^b   Bucci, M ^d   Scagnolari, C ^d   Degener, A M ^d   Capobianchi, M R ^b   Antonelli, Guido ^d   Dianzani, F ^b  

^a UNIVERSITY CAMPUS BIO MEDICO   (Italy)

^b NATIONAL INSTITUTE FOR INFECTIOUS DISEASES L SPALLANZANI   (Italy)

^c CENTRO DI RIFERIMENTO ONCOLOGICO   (Italy)

^d SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Cervical dysplasia; DNA load; Genotypes; Human immunodeficiency virus; Human papillomavirus; Virological markers

Indexed keywords

VIRUS DNA;

ADULT; ARTICLE; CD4+ T LYMPHOCYTE; CONDYLOMA; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE MARKER; DISEASE SEVERITY; FEMALE; GENOTYPE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTERMETHOD COMPARISON; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; NONHUMAN; PAPANICOLAOU TEST; PATHOPHYSIOLOGY; PREVALENCE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; UTERINE CERVIX CYTOLOGY; UTERINE CERVIX DYSPLASIA; VIRUS GENE; VIRUS LOAD; VIRUS VIRULENCE; WART VIRUS;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN PAPILLOMAVIRUS;

EID: 33845287683     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1111/j.1469-0691.2006.01568.x     Document Type: Article

References (14)

1. Burd EM. Human papillomavirus and cervical cancer. Clin Microb Rev 2003; 16: 1-17.
2. Koutsky L, Kiviat N. Genital human papillomavirus. In: Holmes KK, Sparling PF, Mardh PA et.al., eds, Sexually transmitted diseases. New York: McGraw-Hill, 1999; 1089-1132.
3. Munõz N, Bosch FX, de SanjosèS et al. Epidemiologic classification of the human papillomavirus type associated with cervical cancer. New Engl J Med 2003; 348: 518-527.
4. Cubie HA, Seagar AL, Beattie GJ et al. A longitudinal study of HPV detection and cervical pathology in HIV infected women. Sex Transm Infect 2000; 76: 257-261.
5. Palefsky JM. Cervical human papillomavirus infection and cervical intraepithelial neoplasia in women positive for human immunodeficiency virus in the era of highly active antiretroviral therapy. Curr Opin Oncol 2003; 15: 382-388.
6. Ferenczy A, Coutlee F, Franco E, Hankins C. Human papillomavirus and HIV coinfection and the risk of neoplasias of the lower genital tract: A review of recent developments. CMAJ 2003; 16: 431-434.
7. National Cancer Institute Workshop. The revised Bethesda System for reporting cervical/vaginal cytological diagnoses. Report of 1991 workshop. Anal Quant Cytol Histol 1992; 14: 161.
8. Manos MM, Ting Y, Wright DK, Lewis AJ, Broker TR, Wolinsky SM. Use of polymerase chain reaction amplification for the detection of genital human papillomaviruses. Cancer Cells 1989; 7: 209-214.
9. Kleter B, van Doorn LJ, Schrauwen L et al. Development and clinical evaluation of a highly sensitive PCR-reverse hybridisation line probe assay for detection and identification of anogenital human papillomavirus. J Clin Microbiol 1999; 37: 2508-2517.
10. De Francesco MA, Gargiulo F, Schreiber C, Ciravolo G, Salinaio F, Manca N. Detection and genotyping of human papillomavirus in cervical samples from Italian patients. J Med Virol 2005; 75: 588-592.
11. Strickler HD, Burk RD, Fazzari M et al. Natural history and possible reactivation of human papillomavirus in human immunodeficiency virus-positive women. J Natl Cancer Inst 2005; 97: 577-586.
12. Weissenborn SJ, Funke AM, Hellmich M et al. Oncogenic human papillomavirus DNA loads in human immunodeficiency virus-positive women with high-grade cervical lesions are strongly elevated. J Clin Microbiol 2003; 41: 2763-2767.
13. Lefevre J, Hankins C, Money D et al. Human papillomavirus type 16 viral load is higher in human immunodeficiency virus-seropositive women with high-grade squamous intraepithelial lesions than in those with normal cytology smears. J Clin Microbiol 2004; 42: 2212-2215.
14. Fontaine J, Hankins C, Mayrand MH et al. High levels of HPV-16 DNA are associated with high-grade cervical lesions in women at risk or infected with HIV. AIDS 2005; 19: 785-794.